MORE►
American Cancer Society
Bridge Labs at Pegasus Park is at right with the campus's 18-story office tower literally bridged to it on the left. [Photo: Mauricio Rojas]
Cancer-Fighting Biotech to Move Research Operations to Dallas After ACS ‘Golden Ticket’ Win
by Lance Murray | Mar 24, 2025
Jibe Therapeutics is developing a next-generation cancer treatment that helps the immune system better recognize and attack tumors. As a result of its "Golden Ticket" pitch competition win, Jibe is relocating its research operations to Dallas' Pegasus Park.
by Lance Murray |
Oct 24, 2024
Oncology companies seeking seed-stage through Series A funding are invited to apply to the Golden Ticket Pitch Competition, which will be held on March 11, 2025.
MORE►
by Lance Murray |
Nov 6, 2023
The gift, the largest to date for BrightEdge, will fund a "first-of-its-kind program" called the ACS BrightEdge Texas Accelerator. The two-year pilot innovation program will invest in cutting-edge companies making headway in the fight to eliminate cancer.
MORE►
by David Seeley |
Jul 25, 2023
Awarded to 101 community-based organizations across the state—including many in North Texas—the Blue Impact grants focus on health care access and target impacts of socio-economic and social determinants of health.
MORE►
Wayne White, president and CEO of Communities Foundation of Texas [Photo: CFOT]
Communities Foundation of Texas Taps American Cancer Society EVP as Its Next President and CEO
by Glenn Hunter | Jun 30, 2023
Communities Foundation of Texas, which has more than $1 billion in assets and ranks as the seventh-largest foundation in Texas, has named a veteran corporate and nonprofit executive to be its next president and chief executive officer.
Wayne White, currently executive vice president of the American Cancer Society in the Chicago area, was tapped to succeed former president and CEO Dave Scullin, who retired in March....
MORE►
by David Seeley |
Dec 20, 2022
The early-stage startup's QmTRIAGE software platform uses AI and machine learning to detect early breast cancers with a "high rate" of accuracy, MedCognetics says. The company has worked with UT Southwestern and UT Dallas to ensure its AI improves outcomes for "all ethnicities," at a time when racial disparities in AI have become a growing concern.
MORE►
